comparemela.com

Vicki Keedy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Will High-Dose Ifosfamide Become the Go-To Therapy in Recurrent Ewing Sarcoma?

Data from European rEECur trial 'are potentially practice changing,' expert says

United statesFort pierceVicki keedyEd susmanGemcitabine gemzarMartin mccabeAmerican society of clinical oncologyVanderbilt university in nashvilleUniversity of manchesterAmerican cancer societyAmerican societyClinical oncologyVanderbilt universityAmerican cancer

An Intriguing Failure in Advanced, Pre-Treated GIST

Second-line ripretinib unable to best sunitinib, but still had meaningful clinical activity

United statesDana farber cancer instituteVicki keedyMichael heinrichMike bassettRipretinib qinlockVanderbilt university medical centerAmerican society of clinical oncologyOregon healthScience university knight cancer instituteAmerican societyClinical oncologyVirtual plenaryGeorge demetri

Deciphera Pharmaceuticals Presents Results from the INTRIGUE Phase 3 Clinical Study at the American Society of Clinical Oncology Plenary Series Session

– Efficacy Observed with QINLOCK® was Comparable to Sunitinib with a More Favorable Safety and Tolerability Profile in GIST Patients Previously Treated with Imatinib – . | January 24, 2022

United statesHong kongUnited kingdomVicki keedyMichael heinrichVanderbilt university medical centerAmerican society of clinical oncologyDrug administrationDeciphera pharmaceuticalsDeciphera pharmaceuticals incExchange commissionEuropean unionDana farber cancer instituteClinical cancer researchAmerican societyClinical oncology

Deciphera Pharmaceuticals Pres - GuruFocus com

GuruFocus Article or News written by Business Wire and the topic is about:

United statesHong kongUnited kingdomVicki keedyMichael heinrichVanderbilt university medical centerAmerican society of clinical oncologyDrug administrationDeciphera pharmaceuticalsDeciphera pharmaceuticals incExchange commissionEuropean unionDana farber cancer instituteClinical cancer researchAmerican societyClinical oncology

vimarsana © 2020. All Rights Reserved.